Our data indicate that COL23A1 may be a novel prognostic indicator in ccRCC and might be a specific and accessible biomarker as well as a potential new target for clinical diagnosis of ccRCC. The gene discussed is COL23A1; the disease is nonpapillary renal cell carcinoma.